rs157705

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_145331.3(MAP3K7):c.*1085G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The gene MAP3K7 is a tumor suppressor gene (CancerMine: 6 TSG, 7 oncogene, 2 driver citations). The gene MAP3K7 is a known oncogene (CancerMine: 6 TSG, 7 oncogene, 2 driver citations). The gene MAP3K7 is a cancer driver gene (CancerMine: 6 TSG, 7 oncogene, 2 driver citations). The variant allele was found at a cumulative frequency of 0.357 (AC=54,190) in the gnomAD database across 151,652 control chromosomes, including 10,033 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.443. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 10033 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

MAP3K7
NM_145331.3 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.906

Publications

11 publications found
Variant links:
Genes affected
MAP3K7 (HGNC:6859): (mitogen-activated protein kinase kinase kinase 7) The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
MAP3K7 Gene-Disease associations (from GenCC):
  • cardiospondylocarpofacial syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • frontometaphyseal dysplasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina
  • frontometaphyseal dysplasia 2
    Inheritance: AD Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_145331.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.443 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_145331.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MAP3K7 NM_145331.3
MANE Select
HGVSc / HGVSpc.*1085G>A
Exon rankExon 17 of 17
3_prime_UTR
Prot: NP_663304.1UniProt: O43318-1
MAP3K7 NM_003188.4
HGVSc / HGVSpc.*1085G>A
Exon rankExon 16 of 16
3_prime_UTR
Prot: NP_003179.1UniProt: O43318-2
MAP3K7 NM_145332.3
HGVSc / HGVSpc.*1233G>A
Exon rankExon 16 of 16
3_prime_UTR
Prot: NP_663305.1UniProt: O43318-3

Ensembl Transcripts

MAP3K7 ENST00000369329.8
TSL:1MANE Select
HGVSc / HGVSpc.*1085G>A
Exon rankExon 17 of 17
3_prime_UTR
Prot: ENSP00000358335.3UniProt: O43318-1
MAP3K7 ENST00000369332.7
TSL:1
HGVSc / HGVSpc.*1085G>A
Exon rankExon 16 of 16
3_prime_UTR
Prot: ENSP00000358338.3UniProt: O43318-2
MAP3K7 ENST00000369325.7
TSL:1
HGVSc / HGVSpc.*1233G>A
Exon rankExon 16 of 16
3_prime_UTR
Prot: ENSP00000358331.3UniProt: O43318-3

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.357
AC:54134
Hom:10024
AN:151534
Cov:32
GnomAD4 exome Warning
AC:0
Hom:0
AN:0
Cov:0
GnomAD4 genome
AF: 0.357
AC:54190
Hom:10033
AN:151652
Cov:32
TOPMed (Bravo)
AF: 0.365
AC:96649
Hom:18063
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.335
AC:77426
Hom:13174
AN:231070
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.335
AC:784
Hom:131
AN:2342
ChinaMAP Phase 1
AF: 0.314
Denmark Genome
AF: 0.397
AC:119
AN:300
GenomeAsia100K
AF: 0.355
AC:1235
AN:3466
Korea4K (4,157 Koreans)
AF: 0.320
AC:2310
AN:7210
Qatari Genome
AF: 0.392
AC:69
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.336
AC:40898
Hom:6869
AN:121788
Turkish Variome
AF: 0.354
AC:547
Hom:99
AN:1546
UK10K
AF: 0.322
AC:2434
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.307
AC:2755
Hom:424
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.179 405022656 0.0863 251829164
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Uncertain16
BayesDel_noAF
Benign-0.71
CADD
Benign7.5
DANN
Benign0.71
GPN-Star LLR
N/A-0.58
GPN-Star score
N/A0.58
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.91
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.